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Abstract
Postpartum purulent-septic complications (PPSC) and their problems are most urgent for modern obstetrics due to their 
significant frequency. Maternal sepsis is one of the leading causes of maternal mortality around the world, accounting for about 
one-tenth of the global number of maternal deaths. Understanding the risk factors for the development of septic complications of 
puerperium is important for preventive strategies. 
Aim. To study the possibility of forming high-risk groups on the basis of analysis of anamnestic data and the course of puer-
perium in women with PPSC as part of the preventive measures for the development of such complications.
Materials and methods. The first stage of the study involves a retrospective analysis for the allocation of risk factors for the 
development of PPSC in women, who underwent inpatient treatment for this pathology - main group (n=108); сontrol group (n=35) – 
parous with uncomplicated flow of the postpartum period. Prospective research enrolled 65 pregnant women with extragenital pathol-
ogy and/or complicated pregnancy (group 1); 30 pregnant women without severe concomitant somatic pathology with physiological 
course of pregnancy (group 2). The following were taken into account: age, obstetrical and gynecological history, extragenital patholo-
gy, laboratory diagnostic data. Differences in mean values were considered significant with a probability level of at least 95 % (p<0.05).
Results. To the risk factors for the development of PPSC, we classified as follows: gynecological diseases in history: men-
strual dysfunction, chronic inflammatory diseases of the genital organs, bacterial vaginosis; complications of pregnancy and labor: 
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preeclampsia, preterm labor, premature rupture of membranes, long anhydrous span, chorioamnionitis, weakness of labor, genital 
tract ruptures, placental attachment pathology, operative vaginal birth, bleeding; concomitant extragenital pathology: diabetes, obe-
sity, diseases of the urinary system, diseases of the cardiovascular system, respiratory diseases, varicose disease, anemia.
Conclusions. The connection between the presence of concomitant somatic pathology, the complicated course of pregnancy 
and labor and the subsequent development of septic complications in the postpartum period have been established. Prediction of the 
risk of their occurrence at the stage of pregraviditic preparation, with various complications of pregnancy and childbirth, especially 
in women with extragenital pathology, differential prevention will reduce the frequency of PPSC.
Keywords: postpartum purulent-septic complications, risk factors, prevention, vitamin D.
DOI: 10.21303/2504-5679.2018.00627 © Yuliya Feyta, Vira Pyrohova
1. Introduction
Bacterial infections during childbirth and in puerperium are among the leading causes of 
maternal mortality worldwide, accounting for about 10.7 % of all maternal deaths [1, 2]. Most of the 
estimated 75000 maternal deaths worldwide occur every year as a result of infections are recorded 
in low-income countries, while in high-income countries 0.1–0.6 per 1000 births [3, 4]. WHO es-
timates the global incidence of puerperal infections at 4.4 % among live births, representing more 
than 5.7 million cases per year [4].
Several factors influence the development of the septic process: the presence of the pathogen 
(its amount, virulence, associativity), the state of the primary infection and the immune homeosta-
sis (changes in which cause increased sensitivity to infection and create preconditions for activation 
of the microflora).
The degree of colonization by the microorganisms of the vagina and the cervical canal plays 
an important role – massive insemination contributes to the development of the infectious process. 
Especially high risk of ascending infection in pregnant women with concomitant extragenital pa-
thology [5, 6]. Changing the microflora of the vagina during pregnancy can lead to the penetration 
of microorganisms into the amniotic fluid, increasing the risk of developing complications such as 
chorioamnionitis, premature rupture of membranes (PROM), preterm labor, increasing the risk of 
damage of the soft tissues of the genital tract and injuries of the perineum in labor, as well as post-
partum endometritis and subinvolution of uterus as a veiled form, which ultimately can lead to the 
generalization of the process and the development of sepsis [1, 7].
The postpartum period is the most dangerous in terms of the development of infectious 
complications, due to certain features: the change in the anatomical and functional state of the 
genital organs and other systems of the body during pregnancy and childbirth; a change in the 
nature and virulence of microorganisms at the background of reduced immunological status that 
accompanies pregnancy [1, 5].
In the course of physiological pregnancy, non-specific T-cell suppression (decrease in the 
absolute number of T-lymphocytes, increase in the absolute and relative number of T-suppressors, 
decrease in any degree of T-helper cells) is formed, which provides the immunological tolerance 
of the body of the pregnant woman to the fetus [1]; B-cell immunity is maintained at the normal 
level, including the concentration of serum Ig in the blood (compensatory response to the exclusion 
of T-cells from anti-infective protection) [8]. Most authors confirm that a normal pregnancy is ac-
companied by a transient partial immunodeficiency. Presence of genital and extragenital pathology 
deepens the state of immunosuppression [1].
Particularly relevant is the study of vitamin D role in the formation of immune status during 
pregnancy, accounting the high prevalence of vitamin D deficiency in pregnant women (18–84 %) 
[9]. As shown in many studies, vitamin D has a regulatory role on innateand adaptive immune 
responses [10]. Vitamin D is known as an immunomodulator, targeting different immune cells, 
including monocytes, dendritic cells, as well as T-lymphocytes and B-lymphocytes [11]. Vitamin D 
promotes antimicrobial responses by producing antibacterial peptides and stimulating autophagic 
activity in macrophages [10]. Several epidemiological studies link inadequate levels of vitamin D 
with immune status in chronic infections, autoimmune diseases, type 1 diabetes, systemic lupus er-
ythematosus and rheumatoid arthritis [11, 12]. Vitamin D3 deficiency during pregnancy is associat-
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ed with an increased risk of infectious complications of pregnancy, including premature birth [13], 
development of gestational diabetes mellitus, preeclampsia and maternal bacterial vaginosis [9, 14].
Understanding the risk factors for the development of PPSC is important for preventive 
strategies. This explains the urgency of further studying the problem and finding effective preven-
tion technologies.
2. Aim of research
To study the possibility of forming high-risk groups on the basis of analysis of anamnestic 
data and the course of puerperium in women with PPSC as part of the prevention measures for the 
development of such complications.
3. Materials and methods
The first stage of the study involves a retrospective analysis for the allocation of risk factors 
for the development of purulent-septic complications in women, who underwent inpatient treatment 
for this pathology of the postpartum period in Lviv Regional Clinical Hospital and Lviv Municipal 
Clinical First Aid Hospital in 2013–2016 – main group (n=108). Control group (n=35) – parous with 
an uncomplicated flow of the postpartum period.
At the prospective study, 2 groups of pregnant women were formed, depending on the pres-
ence/absence of the following risk factors on the first stage: group 1 (n=65) – pregnant women with 
extragenital pathology and/or complicated pregnancy; group 2 (n=30) – pregnant women without 
severe concomitant somatic pathology with physiological course of pregnancy. The following data 
were taken into account: age, obstetrical and gynecological history, extragenital pathology, labo-
ratory diagnostics data. Concentrations of Ig M, Ig A, Ig G were determined in peripheral blood 
during the last trimester of pregnancy and after delivery by immuno-enzymatic method using 
the firms «Vector Best» (Russia) in accordance with the instructions of the manufacturer. Level 
25(OH)D3 was measured in the peripheral blood during the last trimester of pregnancy by an 
immunochemical method with electrochemiluminescent detection (ECLIA) on the Cobas 6000 
analyzer (Roche Diagnostics test-system, Switzerland).
Statistical processing of the study results was conducted using the Student’s t-criteri-
on. Differences in mean values were considered significant with a probability level of at least 
95 % (p<0.05).
4. Results
At the first stage of this research, a retrospective analysis of archival medical records was 
carried out on 108 women (main group) with PPSC, of which 67.59 % (n=73) of women with PPSC, 
who had vaginal delivery, 32.41 % (n=35) of women with PPSC, who had caesarean section. In 
control group: 68.57 % (n=24) of women had vaginal delivery; 31.43 % (n=11) of women had cae-
sarean section. Both clinical groups were homogeneous according to age, place of residence, socio- 
economic status.
The average age of parous from control group was 27.66±0.73 years, main group – 27.05± 
±0.46 years. It was found the prevalence of women of early and active reproductive age (18–30 years) 
in both groups: main group – 75.93 %, control group – 68.57 %.
In both groups, more than half women had 2 and more pregnancies – 62.96 % (main group) 
and 57.14 % (control group). It was found that in women with PPSC this pregnancy ended up 
preterm labor, that was significantly higher (12.96 %) in comparison to the control group (p<0.05).
In 88.89 % of patients with complicated postpartum period and in 97.14 % of women in 
control group menarche age has reached at the age range of 11-14 years, while in main group the 
number of women with late menarche was 4 times higher than in control group. The disorders of 
menstrual function were 6 times more common in women of main group (54.63 %) compared to 
the control group (8.57 %) (p<0.001).
The analysis of the transferred gynecological diseases has shown a significant frequency 
of inflammatory diseases of genital organs (21.30 %), bacterial vaginosis and colpitis (57.41 %) in 
history of the main group, against 2.86 % and 8.57 % respectively in the control group (p<0,05). Pa-
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thology of the cervix in history of women with PPSC met significantly more (22.22 %) compared to 
the control group (8.57 %) (p<0.05). In addition, infertility and polycystic ovary syndrome (PCOS), 
were registered only among women from the main group (3.70 %).
Table 1
Peculiarities of gynecological history of women with PPSC in comparison to the control group
Indicator Main group (n=108) Control group (n=35)
Menarche (late), % 11.11* 2.86
Menstrual function disturbances, %: 54.63* 8.57
Сhronic inflammatory diseases of the appendages and uterus, % 21.30* 2.86
Bacterial vaginosis, colpitis, % 57.41* 8.57
Benign tumors of the uterus and appendages, % 9.26 2.86
Pathology of the cervix, % 22.22* 8.57
Infertility, PCOS, % 3.70 –
Note: * – p<0.05 between main group and control group
It should be noted, that 29.63 % of women with PPSC had complicated pregnancy with a 
threat of interruption at different terms, 14.81 % had preeclampsia, which is significantly higher 
than in women with uncomplicated course of postpartum period (p<0.05). PROM, long anhydrous 
span, chorioamnionitis were noticed in 13.89 % of women from the main group, while in control 
group such complications were not met at all. Level of birth canal trauma (vagina and perineal rup-
ture, perineo-, episiotomy) in main group was three times higher than in control group (p<0.05). 
Clinically narrow pelvis (3.70 %) was diagnosed in labor only in women of the main group; labor 
complicated by the weakness of labor activity (8.33 %), overlapping forceps and symphysis rupture 
(3.70 %), bleeding and the development of hemorrhagic shock (12.96 %). Placental attachment pa-
thology, manual removal of placenta was observed in 6.48 % of women only in main group. Instru-
mental examinationof the uterine cavity walls during labor was performed in 14.81 % of women 
from the main group, which is almost 5 times higher than in control group (p<0.05).
Table 2
Peculiarities of the course of this pregnancy and delivery in patients with PPSC in comparison to the 
control group
Indicator Main group (n=108) Control group (n=35)
Threat of abortion/preterm birth, % 29.63 11.43
Preeclampsia, % 14.81 2.86
PRM, long anhydrous span, chorioamnionitis, % 13.89 –
Ruptures, perineotomy, perineorrhaphy % 24.07* 8.57
Symphysis rupture, forceps, % 3.70 –
Defect of the placenta, instrumental examination of the uterine cavitywalls, % 14.81* 2.86
Placental attachmentpathology, manual placental separation and removal, % 6.48 –
Clinically narrow pelvis, % 3.70 –
Weakness of labor activity, % 8.33 –
Bleeding, hemorrhagic shock, % 12.96 –
Note: * – p<0.05 between the main group and the control group
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Concomitant extragenital pathology in women with PPSC was found in 2–9 times 
more than in parous with uncomplicated flow of the postpartum period: diseases of the urinary 
system – nine, diseases of the cardiovascular system and respiratory diseases – in five, diabetes and 
obesity – twice, anemia – three times higher than in the control group (p<0.05). Varicose disease is diag-
nosed only in women with PPSC (8.33 %). The considerable frequency of the thyroid pathology attracts 
attention not only in the main group (19.44 %), but also in the control group (17.14 %). In both groups, the 
percentage of childhood infectious diseases and acute respiratory infections in history was significant.
Table 3
Peculiarities of somatic anamnesis and extragenital pathology in patients with PPSC and the control group
Indicator Main group (n=108) Control group (n=35)
Childhood infectious diseases, acute respiratory infections, % 87.96* 60.00
Diseases of the respiratory organs, % 13.89* 2.86
Gastrointestinal diseases, % 12.04 5.71
Cardiovascular diseases, % 13.89* 2.86
Varicose disease, % 8.33 –
Diseases of the urinary system, % 26.85* 2.86
Thyroid diseases, % 19.44 17.14
Diabetes mellitus, obesity, % 26.85* 11.43
Anemia, % 79.63* 25.71
Note: * – p<0.05 between the main group and the control group
According to our analysis, it was found that complaints from women with PPSC appeared on 
the 11.19±0.78 day of the postpartum period, but hospitalization into the gynecological department 
was only on the 14.07±0.89 day. The duration of inpatient treatment in the obstetrical department 
before delivery in the main group was 8.18±2.25 days (max=22 days), which is approximately 
4 times higher than in the control group. It should also be noted, that inpatient treatment in the 
gynecological department because of PPSC was 11.38±0.62 days (max=63 days). The average du-
ration of antibiotical therapy in main group was 10.4±0.4 days (max=39 days).
It should be noted, that 89.81 % of patients with PPSC had extragenital pathology and/or com-
plications during pregnancy and childbirth (subgroup A), while the proportion of parous without 
extragenital diseases, uncomplicated pregnancy and labor (subgroup B) in the main group was 
only 10.19 %. The average duration of inpatient treatment in subgroup A (12.10±0.81 days) ex-
ceeded such in subgroup B (8.09±0.76 days) (p<0.001). A similar trend was observed regarding the 
duration of antibiotic therapy: 11.36±0,76 days (subgroup A) versus 7.18±1.19 days (subgroup B) 
(p<0.05). A gynecological hospital admission status of patients subgroup B was rated as satisfacto-
ry or moderate. The diagnosis: «peritonitis», «sepsis,» «septic shock» have been exposed to women 
only from subgroup A. Also in this subgroup were held hysterectomy, blood transfusion, were ap-
pointed imipenem group antibiotics. Analyzing the data of bacteriological studies discharge from 
the uterus, we noted that in women from subgroup A pathogens were represented in associations, 
while in subgroup B mainly monoinfection was found.
Summing up the findings, we hypothesized that there is a definite link between the presence 
of concomitant extragenital pathology, complicated pregnancy and childbirth, and the subsequent 
development of PPSC.
Based on the above analysis, in the second stage prospectively we examined the state of 
immunity in pregnant women with extragenital pathology and complicated pregnancy (group 1) 
compared to pregnant women without severe extragenital pathology and uncomplicated pregnancy 
(group 2). Both groups were homogeneous according to age, place of residence, socio-economic 
status, term of gestation.
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Structure of diagnoses in patients with PPSC




– peritonitis, % 5.56
– sepsis, septic shock, % 7.41
Infection of a surgical wound, % О86.0 12.96
Thrombophlebitis, phlebothrombosis, % О87.0–О87.1 12.96
Thromboembolism of the pulmonary artery, % О88.3 1.85
Thrombosis of cerebral veins in the postpartum period, % О87.3 4.63
Mastitis, % О91.1 1.85
Apyous mastitis associated with childbirth, % О91.2 13.89
Acute adnexitis, % О86.1 1.85
Other complications of the postpartum period: 
О90.8
– subinvolution of uterus, % 25.93
– lochiometra, % 50.93
– placental polyp, % 7.41
– symphysitis, % 1.85
– pseudomembranous colitis, % 1.85
– postpartum hemorrhage, % 14.81
Table 5
Structure of extragenital pathology in group 1 and group2
Indicator Group 1 (n=65) Group 2(n=30)
Diseases of the respiratory organs, % 9.23 –
Gastrointestinal diseases, % 10.77 3.33
Cardiovascular diseases, % 23.08* 3.33
Varicose disease, % 12.31 –
Thrombophlebitis, hemorrhoids, % 9.23 –
Diseases of the urinary system, % 21.54* 3.33
Thyroid diseases, % 58.46* 23.33
Diabetes, % 7.69 –
Blood diseases, % 7.69 –
Anemia, % 41.54* 20.00
Note:* – p<0.05 between group 1 and group 2
A decrease of Ig A and an increase of Ig G and Ig M in serum before delivery in group 1 was 
observed in comparison to group 2. There was a faster growth in the postpartum period of Ig M and 
Ig A levels in group 1 (in 1.6 and 1.5 times respectively), compared with group 2 (1.4 and 1.3 times 
respectively), and more slowed Ig G growth in group 1 compared to group 2. The results indicated 
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a difference in the immune response in pregnant women with extragenital pathology and somatic 
healthy pregnant women with a physiological course of pregnancy.
a                                                       b
Fig. 1. Indicators of humoral immunity in group 1 and group 2: a – before labor; b – after labor
The D-status was evaluated in accordance to the recommendations: normal level – 30 
–50 ng/ml, suboptimal level – 20–30 ng/ml, moderate deficiency – 10–20 ng/ml, severe deficiency 
<10 ng/ml. Vitamin D deficiency was determined by the level of 25(OH)D3 in blood serum.
Table 6
The level of vitamin D in blood serum
Vitamin D concentration group 1 (n=65) group 2 (n=30) 
<10 ng/ml (severe deficiency), % 32.31 13.33*
10–20 ng/ml (moderate deficiency), % 46.15 30.00
20–30 ng/ml (suboptimal level), % 21.54 43.33*
>30 ng/ml (normal level), % – 13.33 
Note:* – p<0.05 between group 1 and group 2
The results of vitamin D3 levels in blood serum of women from group 1 showed a change in 
comparison to women from group 2 towards a more severe deficiency of vitamin D. The proportion 
of women with severe vitamin D3 deficiency in group 1 (32.31 %) was in 2.4 times higher than in 
group 2 (13.33 %) (p<0.05). While the number of women with suboptimal level of vitamin D3 in 
group 2 twice exceeded this indicator in group 1 (43.33 % and 21.54 % respectively) (p<0.05).
5. Discussion
Under current conditions PPSC are characterized by changes in etiology, often atypical 
clinical symptoms and course, which leads to delayed diagnosis and inadequate treatment [1, 15]. 
The key role in the pathogenesis of PPSC plays «risk factor» [2, 4]. 
Among the risk factors for the development of PPSC are menstrual function disorders, in-
flammatory diseases of the genitals, a significant frequency of bacterial vaginosis and colpitis in 
history of the main clinical group compared to the control group (p<0.05). Similar results were 
presented in the works of other authors [1, 7].
We found that in women with PPSC this pregnancy was complicated by the threat of in-
terruption on different terms and preeclampsia, which is significantly higher than in the group of 
women with uncomplicated flow of the postpartum period (p<0.05). Other authors also noted a 
strong association between preeclampsia/eclampsia and septic processes in the postpartum period 
[16, 15]. This pregnancy was significantly more likely to be completed with preterm labor in wom-
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Clinically narrow pelvis was diagnosed in labor only in women with PPSC; the delivery was 
complicated by the weakness of labor, symphysis rupture and forceps, bleeding and the develop-
ment of hemorrhagic shock. Postpartum haemorrhages were associated with progression to severe 
sepsis and defined as risk factors for severe sepsis in studies by other authors [15, 16].
Long anhydrous span, chorioamnionitis, placental attachment pathology, manual placental 
separation and removal were observed only in women with PPSC. Indicator of instrumental exam-
inations of the uterine cavity walls in deliveries in the main group was almost 5 times higher than 
such in the control group (p<0.05). These factors were also highlighted by other researchers [5, 6].
Level of birth canal trauma in the group of women with PPSC was three times higher than 
that in the control group (p<0.05). These complications are also highlighted in other studies as a 
possible risk factor for the development of PPSC [4, 7].
We found that the concomitant extragenital pathology (diabetes, obesity, diseases of the 
urinary system, cardiovascular diseases, respiratory diseases, anemia) in women with PPSC 
was found much more frequent than in parous with uncomplicated postpartum period (p<0.05). 
Acosta C. D. et al. [15] identified diabetes as a risk factor for sepsis, and in women with diabetes 
the risk of severe sepsis was 47 % higher. In a number of studies, chronic hypertension is defined as 
a risk factor for severe sepsis [1, 15]. The associations between maternal sepsis and cardiovascular 
diseases are found in Al-Ostad et al. [16] study. Bamfo J. [6] noted that obese women have 3.5 times 
higher risk of infection compared with women of an ideal body mass index. Anemia, as a risk factor 
for the development of PPSC, is highlighted by other authors [5, 17].
Analyzing all the data, we found that significantly more (p<0.05) women with PPSC had 
concomitant extragenital pathology and/or complicated pregnancy and labor. A gynecological hos-
pital admission status of such patients was rated as severe or moderate. The average length of inpa-
tient treatment stay in such cases was significantly higher in the parous with extragenital pathology 
(p<0.001). A similar trend was observed regarding the duration of antibiotical therapy (p<0.05). 
The postpartum period is very dangerous because of the development of infectious compli-
cations, which is due to a decrease in the immunological status, which accompanies the pregnancy. 
We have identified the differences in the indicators of humoral immunity in pregnant women with 
concomitant extragenital pathology and/or complicated pregnancy and in pregnant women without 
severe extragenital pathology. Increasing the levels of Ig M, Ig A, Ig G in healthy women testifies 
to the natural mechanisms of humoral protection of a woman’s body in the postpartum period from 
a possible infection, and in the absence of risk factors these mechanisms are sufficient. 
The role of vitamin D is due to his involvement in the immune system response to bacterial 
invasion [18]. Flynn L. et al. [19] have found that in patients with vitamin D levels <20 ng/ml, the 
incidence of infection rates was generally higher, the frequency of septic complications increased. Vi-
tamin D levels <20 ng/ml have a significant impact on the duration of treatment, increasing it [19, 20]. 
Our studies have shown, that in group 1 various degrees of vitamin D deficiency were found 
in all women, in group 2 – 13,33 % had a sufficient level of vitamin D. Women with vitamin D de-
ficiency were twice more in group 1 versus group 2 (78 % and 43 % respectively). The proportion 
of women with severe deficiency of vitamin D in group 1 is higher than twice that in group 2. We 
have found a more marked deficiency of vitamin D in pregnant women with extragenital pathology 
and complicated pregnancy.
6. Conclusions
1. The connection between the presence of somatic pathology, the complicated pregnancy 
and labor and the subsequent development of PPSC have been established.
2. The risk factors for the development of PPSC include:
– gynecological diseases in history: menstrual function disorders, chronic inflammatory 
diseases of the genital organs, bacterial vaginosis;
– complications of pregnancy and labor: preterm labor, preeclampsia, long anhydrous span, 
chorioamnionitis, weakness of labor, genital tract ruptures, placental attachment pathology, oper-
ative vaginal birth, bleeding;
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– concomitant extragenital pathology: diabetes, obesity, diseases of the urinary system, dis-
eases of the cardiovascular system, respiratory diseases, varicose disease, anemia.
3. The prospect of decreasing the frequency of PPSC is to predict and adequately assess 
the risk of their occurrence at the stage of pregraviditic preparation, with various complications of 
pregnancy and labor, especially in women with extragenital pathology.
4. Conducting differentiated stage-by-stage prevention will reduce the frequency 
of PPSC.
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Abstract
Background: Gestational pyelonephritis (GP) is one of the most common and serious diseases of the middle and second half 
of pregnancy, which complicates approximately 6 % of pregnancies, and is one of the leading causes of non-obstetric pre-delivery 
hospitalization.
Methods. The paper provides data from the open, multicentre, prospective, comparative (parallel group) study in 60 pregnant 
women diagnosed with gestational pyelonephritis, which were divided into two groups 30 subjects each. Patients in the treatment 
group received antibacterial therapy for 7 days + treatment with standard dosage of medicinal product Canephron N for 3 months. 
Patients in the control group received antibiotic therapy alone for 7 days.
Results. The average age of pregnant women at the time of diagnosing was 23±6.23 years; it was the first pregnancy for 
39 women (65 %). The most common complaints at admission to the in-patient department were as follows: lumbar pain (96.2 %), 
dysuria (70.2 %), rise in temperature above 38°C (64.4 %). Leukocyturia and bacteriuria were detected in 100 % of cases with 
prevalence of E. coli in 84.2 % (101 of 120) of cases. By 30 day in GP patients in the treatment group bacteriuria was detected 
in 2/30 (6.67 %) patients, and in the control group – in 5/30 (16.7 %) patients (p 1: 2 <0.05), by 60 day in the treatment group – 
2/30 (6.67 %), in the control group – 8/30 (26.7 %) (p 1: 2 <0.05), respectively, by 90 day – 3/30 (10 %) and 10 (33.3 %), respectively 
(p 1: 2 <0.05). The disease relapsed in 1 of 30 (3.33 %) GP patients in the treatment group and 3/30 (10 %) patients in the control 
group (p 1: 2 <0.05) and 3/30 (10 %) patients in the treatment group with CP, and 7/30 (23.3 %) patients in the control group during 
the follow-up period (p 1: 2 <0.05).
